Category Archives: Product Forecasts

My quick and dirty forecasts for drug delivery (DDEP) and pharmaceutical products with an intent to provide insight and perspective.

DepoMed and the $100 Million Serada Statistical Analysis Delay

Posted on 2011/11/03 by

If you have been following DepoMed lately you are familiar with the disappointing results of the Breeze 3 trial and the impact it will have on Serada their extended release gabapentin DDEP for the treatment of menopausal hot flashes. I … Continue reading →

Posted in Company Strategy, Drug Delivery, Product Forecasts, Product Strategy | Tagged , , , , | Leave a comment